Full metadata record
DC FieldValueLanguage
dc.contributor.authorHo, Mao-Wangen_US
dc.contributor.authorYang, Yun-Liangen_US
dc.contributor.authorLin, Chih-Chaoen_US
dc.contributor.authorChi, Chih-Yuen_US
dc.contributor.authorChen, Hui-Tingen_US
dc.contributor.authorLin, Po-Changen_US
dc.contributor.authorHsieh, Li-Yunen_US
dc.contributor.authorChou, Chia-Huien_US
dc.contributor.authorChu, Wen-Lien_US
dc.contributor.authorWu, Chiou-Pyngen_US
dc.contributor.authorLauderdale, Tsai-Lingen_US
dc.contributor.authorLo, Hsiu-Jungen_US
dc.date.accessioned2014-12-08T15:36:04Z-
dc.date.available2014-12-08T15:36:04Z-
dc.date.issued2014-06-01en_US
dc.identifier.issn0301-486Xen_US
dc.identifier.urihttp://dx.doi.org/10.1007/s11046-014-9753-5en_US
dc.identifier.urihttp://hdl.handle.net/11536/24406-
dc.description.abstractA prospective, cross-sectional study was conducted at a medical center in central Taiwan to understand the prevalence, associated factors, and microbiologic features for oropharyngeal yeast colonization in human immunodeficiency virus-infected outpatients. Oral yeast colonization was detected in 127 (45 %) patients, including 21 (16.5 %) colonized by more than one species. Of the 154 isolates, Candida albicans was the most common species (114, 74 %), followed by Candida dubliniensis (10, 6.5 %), Candida glabrata (10, 6.5 %), Candida tropicalis (7, 4.5 %), and 13 others. We found that receiving antituberculous drug (p = 0.046) or atazanavir (p = 0.045) was two predictors for patients colonized by non-C. albicans species (p = 0.005) and risking mixed yeast colonization (p = 0.009). Even though our data showed that clinical antifungal drugs remained effective in vitro against the colonizing yeasts, the increased mixed yeast colonization indicates a potential issue for controlling mixed infections in hospital settings.en_US
dc.language.isoen_USen_US
dc.subjectHuman immunodeficiency virusen_US
dc.subjectHIVen_US
dc.subjectColonizationen_US
dc.subjectMixed yeasten_US
dc.titleYeast Oropharyngeal Colonization in Human Immunodeficiency Virus-Infected Patients in Central Taiwanen_US
dc.typeArticleen_US
dc.identifier.doi10.1007/s11046-014-9753-5en_US
dc.identifier.journalMYCOPATHOLOGIAen_US
dc.citation.volume177en_US
dc.citation.issue5-6en_US
dc.citation.spage309en_US
dc.citation.epage317en_US
dc.contributor.department生物科技學系zh_TW
dc.contributor.department分子醫學與生物工程研究所zh_TW
dc.contributor.departmentDepartment of Biological Science and Technologyen_US
dc.contributor.departmentInstitute of Molecular Medicine and Bioengineeringen_US
dc.identifier.wosnumberWOS:000336379200009-
dc.citation.woscount0-
Appears in Collections:Articles


Files in This Item:

  1. 000336379200009.pdf

If it is a zip file, please download the file and unzip it, then open index.html in a browser to view the full text content.